Prediction and treatment of asthma in preschool children at risk: Study design and baseline data of a prospective cohort study in general practice (ARCADE)

BMC Pulmonary Medicine

Volumn 9, Issue , 2009, Pages

  van Wonderen, Karina E ^a   van der Mark, Lonneke B ^a   Mohrs, Jacob ^a   Geskus, Ronald B ^a   van der Wal, Willem ^a   van Aalderen, Wim M C ^b   Bindels, Patrick J E ^c   ter Riet, Gerben ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; NITRIC OXIDE; ANTIASTHMATIC AGENT;

ANTIBODY DETECTION; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DISEASE SEVERITY; DRUG USE; DYSPNEA; FEMALE; GENERAL PRACTICE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; TREATMENT RESPONSE; VALIDATION PROCESS; WHEEZING; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; NETHERLANDS; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SPIROMETRY;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NETHERLANDS; PEAK EXPIRATORY FLOW RATE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SPIROMETRY;

EID: 65549103073     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-9-13     Document Type: Article

References (56)

1. Busse WW Lemanske RF Asthma N Engl J Med 2001, 344:350-362. 10.1056/ NEJM200102013440507 11172168
2. Tattersfield AE Knox AJ Britton JR Hall IP Asthma The Lancet 2002, 360:1313-1322. 10.1016/S0140-6736(02)11312-2
3. Sporik R Holgate ST Platts-Mills TA Cogswell JJ Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study N Engl J Med 1990, 323:502-507. 2377175
4. Celedón JC Litonjua AA Ryan L Platts-Mills T Weiss ST Gold DR Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life Lancet 2002, 360:781-782. 10.1016/ S0140-6736(02)09906-3 12241839
5. Melén E Wickman M Nordvall SL van Hage-Hamsten M Lindfors A Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children Allergy 2001, 56:646-652. 10.1034/j.1398-9995.2001.00387.x 11421923
6. Almqvist C Egmar AC van Hage-Hamsten M Berglind N Pershagen G Nordvall SL et al Heredity, pet ownership, and confounding control in a population-based birth cohort J Allergy Clin Immunol. 2003, 111(4):800-806. 10.1067/mai.2003.1334 12704361
7. Strachan DP Cook DG Health effects of passive smoking. 6. Parental smoking and childhood asthma: Longitudinal and case-control studies Thorax 1998, 53:204-212. 1745164 9659358
8. Dezateux C Stocks J Dunas I Fletcher ME Impaired Airway Function and Wheezing in Infancy. The Influence of Maternal Smoking and a Genetic Predisposition to Asthma Am J Respir Crit Care Med 1999, 159(2):403-410. 9927350
9. Gern JE Busse WW Relationship of viral infections to wheezing illnesses and asthma Nat Rev Immunol 2002, 2:132-138. 10.1038/nri725 11910895
10. Sigurs N Bjarnason R Sigurbergsson F Kjellman B Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 Am J Respir Crit Care Med 2000, 161:1501-1507. 10806145
11. Stein RT Sherrill D Morgan WJ Holberg CJ Halonen M Taussig LM et al Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years Lancet 1999, 354:541-545. 10.1016/S0140-6736(98)10321-5 10470697
12. Friedman NJ Zeiger RS The role of breast-feeding in the development of allergies and asthma Journal of Allergy and Clinical Immunology 2005, 115:1238-1248. 10.1016/j.jaci.2005.01.069
13. Horwood LJ Fergusson DM Shannon FT Social and Familial Factors in the Development of Early Childhood Asthma Pediatrics 1985, 75:859-868. 3991272
14. Martinez FD Wright AL Taussig LM Holberg CJ Halonen M Morgan WJ Asthma and wheezing in the first six years of life. The Group Health Medical Associates N Engl J Med 1995, 332:133-138. 10.1056/NEJM199501193320301 7800004
15. Beuther DA Weiss ST Sutherland ER Obesity and Asthma American Journal of Respiratory and Critical Care Medicine 2006, 174:112-119. 10.1164/ rccm.200602-231PP
16. Shore SA Fredberg JJ Obesity, smooth muscle, and airway hyperresponsiveness Journal of Allergy and Clinical Immunology 2005, 115:925-927. 10.1016/j.jaci.2005.01.064
17. Bisgaard H Allen D Milanowski J Kalev I Willits L Davies P Twelve-Month Safety and Efficacy of Inhaled Fluticasone Propionate in Children Aged 1 to 3 Years With Recurrent Wheezing Pediatrics 2004, 113:e87-e94. 10.1542/ peds.113.2.e87 14754977
18. Pao CS McKenzie SA Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze American Journal of Respiratory and Critical Care Medicine 2002, 166(7):945-949. 10.1164/ rccm.200203-265OC
19. Roorda RJ Mezei G Bisgaard H Maden C Response of preschool children with asthma symptoms to fluticasone propionate J Allergy Clin Immunol 2001, 108:540-546. 10.1067/mai.2001.118789 11590379
20. Teper AM Kofman CD Szulman GA Vidaurreta SM Maffey AF Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma American Journal of Respiratory and Critical Care Medicine 2005, 171(6):587-590. 10.1164/rccm.200408-1088OC
21. Balemans WA van der Ent CK Schilder AG Sanders EA Zielhuis GA Rovers MM Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule J Clin Epidemiol 2006, 59(11):1207-1212. 10.1016/j.jclinepi.2006.02.011 17027432
22. Castro-Rodriguez JA Holberg CJ Wright AL Martinez FD A clinical index to define risk of asthma in young children with recurrent wheezing Am J Respir Crit Care Med 2000, 162:1403-1406. 11029352
23. Eysink PE ter Riet G Aalberse RC van Aalderen WM Roos CM van der Zee JS et al Accuracy of specific IgE in the prediction of asthma: Development of a scoring formula for general practice Br J Gen Pract 2005, 55:125-131. 1463187 15720934
24. Steyerberg EW Borsboom GJ van Houwelingen HC Eijkemans MJ Habbema JD Validation and updating of predictive logistic regression models: A study on sample size and shrinkage Statistics in Medicine 2004, 23(16):2567-2586. 10.1002/sim.1844 15287085
25. NHBLI/WHO Workshop Report Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. Revised 2007 National Institutes of Health and National Heart, Lung and Blood Institute. NIH Publication No 02-3659 2007 Ref Type: Report
26. Steyerberg EW Bleeker SE Moll HA Grobbee DE Moons KG Internal and external validation of predictive models: A simulation study of bias and precision in small samples J Clin Epidemiol 2003, 56:441-447. 10.1016/ S0895-4356(03)00047-7 12812818
27. Asher MI Keil U Anderson HR Beasley R Crane J Martinez F et al International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods Eur Respir J 1995, 8:483-491. 10.1183/ 09031936.95.08030483 7789502
28. Stapel SO Eysink PED de Vrieze J Aalberse RC IgE testing in capillary blood Pediatric Allergy and Immunology 2004, 15(3):230-233. 10.1111/ j.1399-3038.2004.00142.x
29. Pijnenburg MW Lissenberg ET Hofhuis W Ghiro L Hop WCJ Holland WP et al Exhaled nitric oxide measurements with dynamic flow restriction in children aged 4-8 yrs Eur Respir J 2002, 20(4):919-924. 10.1183/ 09031936.02.01282002 12412684
30. Kamps AW Roorda RJ Brand PLP Peak flow diaries in childhood asthma are unreliable Thorax 2001, 56:180-182. 1758788 11182008 10.1136/ thorax.56.3.180
31. Cockcroft DW Bronchoprovocation methods - Direct challenges Clinical Reviews in Allergy & Immunology 2003, 24:19-26. 10.1385/ CRIAI:24:1:19 12644716
32. Cockcroft DW Killian DN Mellon JJ Hargreave FE Bronchial reactivity to inhaled histamine: A method and clinical survey Clin Allergy 1977, 7:235-243. 10.1111/j.1365-2222.1977.tb01448.x 908121
33. Harrell FE Jr Regression modelling strategies. With applications to linear models, logistic regression and survival analysis New York Springer 1 A.D
34. Tibshirani R The lasso method for variable selection in the cox model Statistics in Medicine 1997, 16:385-395. http:// www3.interscience.wiley.com/cgi-bin/fulltext/9702/PDFSTART 10.1002/ (SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3 9044528
35. Sauerbrei W Schumacher M A Bootstrap Resampling Procedure for Model-Building - Application to the Cox Regression-Model Statistics in Medicine 1992, 11:2093-2109. 10.1002/sim.4780111607 1293671
36. Harrell FE Lee KL Mark DB Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Statistics in Medicine 1996 15 361 387 10.1002/ (SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 8668867
37. Juniper EF Guyatt GH Feeny DH Ferrie PJ Griffith LE Townsend M Measuring quality of life in children with asthma Qual Life Res 1996, 5:35-46. 10.1007/BF00435967 8901365
38. Raat H Bonsel GJ Essink-Bot ML Landgraf JM Gemke RJBJ Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index J Clin Epidemiol 2002, 55:67-76. 10.1016/S0895-4356(01)00411-5 11781124
39. Robins JM Hernan MA Brumback B Marginal structural models and causal inference in epidemiology Epidemiology 2000, 11:550-560. 10.1097/ 00001648-200009000-00011 10955408
40. Choi HK Hernan MA Seeger JD Robins JM Wolfe F Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study Lancet 2002, 359:1173-1177. 10.1016/S0140-6736(02)08213-2 11955534
41. Cole SR Hernan MA Robins JM Anastos K Chmiel J Detels R et al Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models Am J Epidemiol 2003, 158:687-694. 10.1093/aje/kwg206 14507605
42. Cole SR Hernan MA Margolick JB Cohen MH Robins JM Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count Am J Epidemiol 2005, 162:471-478. 10.1093/ aje/kwi216 16076835
43. Cole SR Hernan MA Anastos K Jamieson BD Robins JM Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model Am J Epidemiol 2007, 166:219-227. 10.1093/aje/ kwm047 17478436
44. Hernan MA Brumback B Robins JM Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 2000, 11:561-570. 10.1097/00001648-200009000-00012 10955409
45. Hernan MA Brumback BA Robins JM Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures Statistics in Medicine 2002, 21:1689-1709. 10.1002/sim.1144 12111906
46. Hernan MA Hernandez-Diaz S Robins JM A structural approach to selection bias Epidemiology 2004, 15:615-625. 10.1097/01.ede.0000135174.63482.43 15308962
47. Hernan MA Robins JM Instruments for causal inference - An epidemiologist's dream? Epidemiology 2006, 17:360-372. 10.1097/ 01.ede.0000222409.00878.37 16755261
48. Hernan MA Robins JM Estimating causal effects from epidemiological data J Epidemiol Community Health 2006, 60:578-586. 10.1136/jech.2004.029496 16790829
49. Sterne JA Hernan MA Ledergerber B Tilling K Weber R Sendi P et al Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study Lancet 2005, 366:378-384. 10.1016/S0140-6736(05)67022-5 16054937
50. Lavori PW Dawson R Dynamic treatment regimes: Practical design considerations Clinical Trials 2004, 1:9-20. 10.1191/1740774S04cn002oa 16281458
51. Moodie EE Richardson TS Stephens DA Demystifying optimal dynamic treatment regimes Biometrics 2007, 63:447-455. 10.1111/ j.1541-0420.2006.00686.x 17688497
52. Murphy SA Optimal dynamic treatment regimes Journal of the Royal Statistical Society Series B-Statistical Methodology 2003, 65:331-355. 10.1111/1467-9868.00389
53. Rosthoj S Fullwood C Henderson R Stewart S Estimation of optimal dynamic anticoagulation regimes from observational data: A regret-based approach Statistics in Medicine 2006, 25:4197-4215. 10.1002/sim.2694 16981226
54. Chen W Purohit A Barnig C Casset A de Blay F Niox (R) and Niox Mino (R): comparison of exhaled NO in grass pollen allergic adult volunteers Allergy 2007, 62:571-572. 10.1111/j.1398-9995.2007.01334.x 17441801
55. Bisgaard H Hermansen MN Loland L Halkjaer LB Buchvald F Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing The New England Journal of Medicine 2006, 354:1998-2005. 10.1056/NEJMoa054692 16687712
56. Guilbert TW Morgan WJ Zeiger RS Mauger DT Boehmer SJ Szefler SJ et al Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma The New England Journal of Medicine 2006, 354:1985-1997. 10.1056/ NEJMoa051378 16687711